Breaking News: South African Researcher Wins Prestigious Award for Cancer Treatment Innovation!
In an inspiring achievement for South African science and healthcare, Dr. Keamogetswe Ramonaheng, a lecturer at the University of Pretoria, has been awarded the prestigious Saul Hertz Award at the 8th Theranostics World Congress (TWC 2026). This recognition is a testament to her groundbreaking work in the field of theranostics, which combines diagnostic imaging with therapeutic applications to improve cancer treatment outcomes.
A Humbling Recognition of Excellence
Dr. Ramonaheng expressed that receiving the Saul Hertz Award was both humbling and profoundly meaningful, as it symbolizes not only her individual efforts but also the collective advancement in cancer treatment. The award pays tribute to her research aimed at enhancing patient-specific dosimetry, a vital aspect of developing safe and effective radionuclide therapies tailored to individual needs.
Advancing Cancer Treatment
Her research focuses on integrating next-generation imaging technologies with quantitative dosimetry frameworks, a critical step in personalizing cancer care. This innovative approach helps create evidence-based treatment plans that improve therapeutic efficacy and overall patient quality of life. By advancing the methods related to alpha-therapy dosimetry, Dr. Ramonaheng places the University of Pretoria among a select few institutions worldwide that are pioneering these specialized techniques.
A Message of Empowerment
The awarding ceremony also featured inspiring words from Barbara Hertz, daughter of the award's namesake Saul Hertz, who emphasized the importance of Dr. Ramonaheng’s contributions as an African woman in nuclear medicine. She highlighted the profound impact of using one's blessings to better humanity—a sentiment that resonates deeply in the context of healthcare advancements.
Global Competitiveness
Dr. Ramonaheng's achievements underscore the global competitiveness of South African research and clinical practices. She noted that this recognition not only showcases individual excellence but also reflects the strength of multidisciplinary collaborations among the University of Pretoria, Steve Biko Academic Hospital, and their national and international partners.
As the field of cancer treatment continues to evolve, Dr. Ramonaheng is at the forefront, championing innovative methods that promise to bridge foundational science with practical applications that significantly benefit local communities. Her work shines a light on the potential for remarkable advancements in healthcare, emphasizing a strong commitment to improving patient outcomes through precision oncology.
